InsiderTrades

Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.

Accepted 2026-06-05 17:03:03 ET · period of report 2026-06-05 · accession 0001856369-26-000023 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2026-06-05 17:03 2026-06-05 RXRX Gibson Christopher Dir C - Cnv Deriv $0.00 +40.0K 923.7K +5% $0
DT 2026-06-05 17:03 2026-06-05 RXRX Gibson Christopher Dir S - Sale $3.62 -40.0K 883.7K -4% -$144.8K
DT 2026-06-05 17:03 2026-06-05 RXRX Gibson Christopher Dir C - Cnv Deriv $0.00 -40.0K 4.26M -0.9% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2026-06-05 C A 40,000 $0.00 923,735 D — — (F1) Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person. Each share of Class B Common Stock is convertible into one share of Class A Common Stock. (F2) This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.
2 Common Class A Common Stock 2026-06-05 S D 40,000 $3.62 883,735 D — — (F2) This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.
3 Derivative Class B Common Stock 2026-06-05 C D 40,000 $0.00 4,263,334 D $0.00 · — to — 40,000 Class A Common Stock (F3) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. (F1) Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person. Each share of Class B Common Stock is convertible into one share of Class A Common Stock. (F2) This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025. (F3) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. (F3) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.